Literature DB >> 2716201

[Acute promyelocytic leukemia with a history of RAEB in transformation and the 15/17 translocation].

K Ogawa, H Shineha, R Abe, T Shichishima, H Kimura, T Yui, M Kawaguchi, S Matsuda, T Uchida, S Kariyone.   

Abstract

A 34-year old female was admitted to our clinic because of fever and general fatigue on March 26, 1987. On admission, peripheral blood (PB) revealed pancytopenia. Bone marrow smears revealed 9. 0% of promyelocytic cells with or without Auer rods. Diagnosis of RAEB in transformation was made. Chromosome study of the bone marrow cells showed t(15; 17) in 3 out of 20 cells analysed. After 3 months, the leukemic cells were observed in PB and increased in number. Then the patient showed bleeding tendency and fibrin degradation products (FDP) increased up to 40 micrograms/ml. And the leukemic cells were over 30% in PB at the end of July, 1987. The diagnosis of APL with DIC was made. To our knowledge, this is the first case of APL with a history of MDS with t(15; 17).

Entities:  

Mesh:

Year:  1989        PMID: 2716201

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  3 in total

Review 1.  Chromosome abnormalities in acute leukemia: its clinical implications and age of onset.

Authors:  R Abe; Y Shiga; T Uchida; S Kariyone
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

2.  Effect of additional chromosomal abnormalities in acute promyelocytic leukemia treated with all-trans-retinoic acid: a report of 17 patients.

Authors:  Y Okoshi; H Akiyama; N Kono; T Matsumura; D Mizuchi; S Mori; K Ohashi; H Sakamaki
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

3.  A case of acute promyelocytic leukemia with morphologic multilineage dysplastic changes.

Authors:  Setsuki Isono; Katsuyasu Saigo; Keiko Nagata; Keiko Numata; Toshiaki Kojitani; Akiharu Okamura; Akihiko Nishizawa; Masafumi Takata; Mariko Takenokuchi; Eiji Tatsumi
Journal:  Hematol Rep       Date:  2013-02-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.